The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review
Trinidad Montero‐Vílchez, Antonio Martínez‐López, Luis Salvador‐Rodríguez, Salvador Arias‐Santiago, Alejandro Molina‐Leyva
Topics & Concepts
Hidradenitis suppurativaMedicineDermatologyDermatological diseasesInternal medicineDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity